Leah Jobson
Medical · Watkinsville, GANPI 1194192732
Payments from drug & device makers
Across 228 payments — averaging $15.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$564
- Novo Nordisk$488
- Pfizer$476
- Boehringer Ingelheim$400
- Takeda Pharmaceuticals U.S.A., Inc.$394
- Amgen$240
- plus $947 from 16 others
What the payments were for
- Food & beverage$3,510100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 38 | $564 |
| Novo Nordisk | 37 | $488 |
| Pfizer | 31 | $476 |
| Boehringer Ingelheim | 24 | $400 |
| Takeda Pharmaceuticals U.S.A., Inc. | 27 | $394 |
| Amgen | 13 | $240 |
| Biohaven Pharmaceuticals, Inc. | 12 | $180 |
| Sanofi-aventis U.S. LLC | 10 | $168 |
| Biohaven Pharmaceutical Holding Company Ltd. | 8 | $121 |
| AstraZeneca | 6 | $96 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $54 |
| GSK | 3 | $50 |
| Johnson & Johnson | 3 | $44 |
| Exact Sciences | 2 | $36 |
| AbbVie | 2 | $35 |
| Eisai Inc. | 2 | $33 |
| Idorsia Pharmaceuticals US Inc | 2 | $30 |
| Boston Scientific | 1 | $27 |
| Astellas Pharma US Inc | 1 | $21 |
| Shield Therapeutics Inc | 1 | $19 |
| Neos Therapeutics, LP | 1 | $16 |
| Adlon Therapeutics L.p. | 1 | $16 |
How this compares
$3,510 in reported general payments places this provider in the 75th percentile of 950 medical providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 20 | $21,414 |
| JardianceEmpagliflozin | 27 | $18,116 |
| Levothyroxine Sodium | 29 | $477 |
| Duloxetine Hcl | 24 | $443 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 14 | $355 |
| Lisinopril | 25 | $218 |
| Amlodipine Besylate | 44 | $193 |
| Gabapentin | 25 | $148 |
| Atorvastatin Calcium | 22 | $146 |
| Omeprazole | 16 | $145 |
| Rosuvastatin Calcium | 19 | $88 |
| Trazodone Hcl | 15 | $86 |
| Losartan Potassium | 25 | $83 |
| SynthroidLevothyroxine Sodium | 12 | $82 |
| Citalopram HbrCitalopram Hydrobromide | 11 | $74 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $488 | $21,41420 claims |
| Boehringer IngelheimJardiance | $400 | $18,11627 claims |
| AbbVieSynthroid | $35 | $8212 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 950 medical providers in Georgia.
Other medical in Watkinsville
- Elena FercilienWatkinsville$71K
- Michael BoydWatkinsville$42K
- Tomas ChaoWoodstock$1.9M
- Kimberly OrleckAtlanta$727K
- Audrey GibsonGainesville$302K
- Lisa WeissCanton$283K
- Laura BushFayetteville$146K
- Michael KelleherMarietta$126K
- Juliena GigonMarietta$122K
- Felicia HoffmanRoswell$114K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.